De la Zerda, who was chosen for the science category, pioneered novel molecular-imaging techniques in which he uses nanotechnology to watch how molecules move within the body, leading to insights at the cellular level of what goes wrong in diseases such as cancer and age-related macular degeneration, a leading cause of blindness.